2024-10-15T22:10:06-05:00 2023-12-31 420714325 RSM US LLP 919 EAST MAIN STREET SUITE 1800 RICHMOND VA 23219 990 2023-01-01 526039142 AMERICAN PHARMACISTS ASSOCIATION FOUNDATION AMER 2026284410 2215 CONSTITUTION AVE NW WASHINGTON DC 20037 BENJAMIN BLUML EXECUTIVE DIRECTOR 2026284410 2024-10-09 1 1 MEREDITH BELL P01696827 8042822121 2024-10-09 2023 2024-10-15 13:58:12Z APHA FOUNDATION BENJAMIN BLUML 2215 CONSTITUTION AVE NW WASHINGTON DC 20037 7654361 0 X WWW.APHAFOUNDATION.ORG X 1953 DC THE MISSION OF THE APHA FOUNDATION IS TO IMPROVE HEALTH BY INSPIRING PHILANTHROPY, RESEARCH AND INNOVATION THAT ADVANCES PHARMACISTS' PATIENT CARE SERVICES. THE APHA FOUNDATION LOOKS TO CREATE A NEW MEDICATION USE SYSTEM WHERE PATIENTS, PHARMACISTS, PHYSICIANS AND OTHER HEALTH CARE PROFESSIONALS COLLABORATE TO DRAMATICALLY IMPROVE THE COST EFFECTIVENESS AND QUALITY OF PATIENT HEALTH OUTCOMES. 7 6 0 50 0 0 3667955 7404506 0 0 152911 197215 9935 9389 3830801 7611110 73870 109867 0 0 1095683 1226142 0 0 328420 2024357 5038810 3193910 6374819 636891 1236291 9514594 11510448 3281705 3585730 6232889 7924718 X THE MISSION OF THE APHA FOUNDATION IS TO IMPROVE HEALTH BY INSPIRING PHILANTHROPY, RESEARCH AND INNOVATION THAT ADVANCES PHARMACISTS' PATIENT CARE SERVICES. THE APHA FOUNDATION LOOKS TO CREATE A NEW MEDICATION USE SYSTEM WHERE PATIENTS, PHARMACISTS, PHYSICIANS AND OTHER HEALTH CARE PROFESSIONALS COLLABORATE TO DRAMATICALLY IMPROVE THE COST EFFECTIVENESS AND QUALITY OF PATIENT HEALTH OUTCOMES. 0 0 5251670 SCIENCE AND RESEARCH - OUR RESEARCH PROJECTS ESTABLISH NEW MODELS OF PRACTICE FOR PHARMACISTS AND REDEFINE PATIENTS HEALTHCARE EXPERIENCE. WE CONNECT EACH PATIENT TO A PHARMACIST WHO EMPOWERS THEM TO BECOME SUCCESSFUL IN MANAGING HIS OR HER OWN HEALTH. OUR WORK VALIDATED THAT THE PHARMACISTS ARE ESSENTIAL TO HELPING PATIENTS ACHIEVE BETTER HEALTH OUTCOMES. THE FOUNDATION RESEARCH PROJECTS INCLUDE IMMUNIZATION REGISTRIES, DIABETES PATIENT CREDENTIALING, DIABETES PREVENTION, RAPID CYCLE INNOVATION, TRIGLYCERIDES AWARENESS AND IMPACT INSTITUTE. 191488 109867 AWARDS AND GRANTS - TO ENCOURAGE THE ENHANCEMENT OF PHARMACISTS SKILLS AND TO PROVIDE BETTER SERVICE TO THE PUBLIC IN THE AREA OF PHARMACEUTICAL CARE. THE FOUNDATION HAS THREE AWARD PROGRAMS: 1. INCENTIVE GRANTS - PROVIDES SEED FUNDING TO PHARMACISTS WHO WANT TO ESTABLISH OR SUPPORT ALREADY EXISTING PATIENT CARE SERVICES WITHIN THEIR PHARMACY PRACTICE.2. PINNACLE AWARDS - ANNUAL RECOGNITION PROGRAM FOR CONTRIBUTIONS TO HEALTHCARE QUALITY THROUGH THE MEDICATION USE PROCESS.3. STUDENT PHARMACISTS PROGRAM - RECOGNIZES STUDENTS WHO HELP SHAPE THE FUTURE OF THE PROFESSION. 5443158 1 1 0 0 0 0 0 1 0 1 1 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 37 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 7 6 0 0 0 0 1 1 0 1 1 0 0 1 1 1 1 1 1 1 0 0 AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY X AMERICAN PHARMACISTS ASSOCIATION 2026284410 2215 CONSTITUTION AVE NW WASHINGTON DC 20037 ILISA BERNSTEIN SECRETARY (THRU 7/23) 2.00 40.00 X X 0 523792 20815 GARY KADLEC TREASURER (THRU 3/23) 2.00 0.00 X X 0 0 0 ANJANETTE WYATT PRESIDENT 2.00 0.00 X X 0 0 0 ELIZABETH JOHNSON VP (THRU 3/23)/DIRECTOR 2.00 0.00 X X 0 0 0 NANCY ALVAREZ DIRECTOR 2.00 0.00 X 0 0 0 MALLORY WARD DIRECTOR/VP (BEG 3/23) 2.00 0.00 X 0 0 0 JOHN GRABENSTEIN TREASURER (BEG 3/23) 2.00 0.00 X X 0 0 0 MICHAEL HOGUE SECRETARY (BEG 7/23) 2.00 40.00 X X 0 333706 34974 VALENTINO CARUSO DIRECTOR 2.00 0.00 X 0 0 0 BENJAMIN BLUML EXEC DIR / SVP OF RESEARCH 40.00 0.00 X 306914 0 106677 BARRY BUNTING PROJECT MANAGEMENT SPECIALIST 40.00 0.00 X 129782 0 44887 JONATHAN LITTLE RESEARCH & INNOVATION PROJ MGMT SPEC 40.00 0.00 X 152571 0 42133 JASON SAPIA DIRECTOR OF DEVELOPMENT 40.00 0.00 X 137910 0 10896 SHANNEN MENDOZA DIRECTOR, OPERATIONS 40.00 0.00 X 107412 0 40279 SCOTT KNOER FORMER SECRETARY 2.00 40.00 X 0 683465 0 834589 1540963 300661 4 1 1 0 CHARLES CATES RED RUBY NETWORKS 5900 BALCONES DRIVE AUSTIN TX 78731 CONSULTING 350000 CANTON AND COMPANY LLC 8100 SANDPIPER CIRCLE BALTIMORE MD 21236 CONSULTING 304408 INFINITERA INC PO BOX 2020 BOULDER CO 80306 TECHNOLOGY DEVELOPMENT CONSULTING 238171 NICOLE SCOVIS DBA CLINICAL PHARMACY INNO 6533 E ELI DRIVE TUCSON AZ 85710 CONSULTING 184778 MISSION BASED MEDIA LTD HERTIAGE BUSINESS CENTRE DERBY ROAD BELPER DERBYSHIRE UK DE56 1 SW MEDIA PRODUCTION 102000 6 693942 1654611 5055953 7404506 193523 193523 46943 43251 3692 3692 3692 MISCELLANEOUS INCOME 900099 9389 9389 9389 7611110 0 0 206604 X 109867 109867 334917 304814 25490 4613 748714 341278 219044 188392 21870 11356 10514 53092 37523 -3439 19008 67549 39712 15511 12326 43886 32375 11511 33927 33927 19605 19605 4557159 4526651 24940 5568 29093 802 9708 18583 81476 46935 34541 49788 8551 855 40382 2384 2384 26965 26965 OVERHEAD 163575 163575 30952 15669 144 15139 6374819 5443158 603241 328420 4134082 4603143 575563 471569 195674 1069339 26965 4625 413437 393374 22447 20063 4559863 5172531 0 169178 9514594 11510448 445570 1292607 2763044 2293123 73091 0 3281705 3585730 X 764729 2040006 5468160 5884712 6232889 7924718 9514594 11510448 1236291 455538 0 X X 0 1 X 1 1 1 X 3312763 1997721 2399374 3667995 7404506 18782359 3312763 1997721 2399374 3667995 7404506 18782359 6358725 12423634 132264 132028 155051 151147 193523 764013 11192 11192 2020 20000 5554 9935 9389 46898 19604462 0.63370 0.77670 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED X 0 4789448 4518 524210 108554 5209622 4991477 582257 -691926 92360 4789448 4531525 49248 484684 73980 4991477 3943545 298051 362445 72516 4531525 2544176 981044 516609 98284 3943545 0.00000 0.74885 0.25115 0 0 353210 333147 20063 60227 60227 0 20063 8047043 455538 455538 7591505 19605 19605 7611110 6355214 0 6355214 19605 19605 6374819 PART III, LINE 1A: THE FOUNDATION ACQUIRED AN ART COLLECTION WITH AN APPRAISED VALUE OF APPROXIMATELY $1,300,000 THROUGH A DONOR CONTRIBUTION IN A PRIOR YEAR. THE COLLECTION WAS RECEIVED WITH A PERMANENT DONOR RESTRICTION THAT THE COLLECTION CANNOT AND SHOULD NOT BE SOLD. IN 2009, THE FOUNDATION COMMISSIONED TWO BRONZE SCULPTURES WHICH DEPICT THE ROLES OF PHARMACISTS. THE COST TO CREATE THESE SCULPTURES WAS APPROXIMATELY $120,000. THE FOUNDATION'S COLLECTIONS ARE HELD FOR PUBLIC EXHIBITION, ARE CARED FOR AND PRESERVED, AND PROCEEDS FROM DE-ACCESSIONS OR INSURANCE RECOVERIES FOR LOST OR DAMAGED COLLECTION ITEMS ARE DESIGNATED FOR FUTURE COLLECTION ACQUISITIONS. UNDER AUTHORITATIVE GUIDANCE ISSUED BY THE FINANCIAL ACCOUNTING STANDARDS BOARD (FASB), THE FOUNDATION HAS THE OPTION OF NOT CAPITALIZING ITS COLLECTIONS. THE FOUNDATION HAS ELECTED NOT TO CAPITALIZE ITS COLLECTIONS, AND ACCORDINGLY, THESE COLLECTIONS ARE NOT RECOGNIZED AS ASSETS IN THE ACCOMPANYING STATEMENTS OF FINANCIAL POSITION. PURCHASE OF COLLECTION ITEMS ARE RECOGNIZED AS REDUCTION IN NON-DONOR-RESTRICTED NET ASSETS IN THE PERIOD OF ACQUISITION. PART III, LINE 4: THE ART COLLECTION, TITLED "GREAT MOMENTS IN PHARMACY," PROVIDES A PICTORIAL HISTORY OF PHARMACY FROM EARLY CIVILIZATION UNTIL THE 1950'S THROUGH A SERIES OF 40 PAINTINGS PAINTED BY THE ARTIST ROBERT THOM. THE FOUNDATION'S ARTICLES OF INCORPORATION STATE THAT "THE PARTICULAR BUSINESS AND OBJECTS OF SAID CORPORATION SHALL BE TO RECEIVE GIFTS, BEQUESTS AND DEVICES OR PROPERTY AND OTHERWISE TO ACQUIRE PROPERTY, REAL AND PERSONAL, OF WHATSOEVER NATURE AND WHERESOEVER THE SAME MAY BE SITUATE TO BE USED EXCLUSIVELY FOR THE ADVANCEMENT OF THE SCIENCE OF PHARMACY AND PHARMACEUTICAL EDUCATION...". THE DISPLAY OF THIS COLLECTION FURTHERS THE FOUNDATION'S EDUCATIONAL PURPOSES AS IT IS AVAILABLE TO ALL VISITORS TO THE HEADQUARTERS BUILDING. REPRODUCTION RIGHTS TO THE IMAGES HAVE BEEN GRANTED FOR USE IN TEXT BOOKS AND OTHER SCHOLARLY BOOKS. PART V, LINE 4: THE FOUNDATION'S PERMANENTLY RESTRICTED NET ASSETS ARE USED TO GENERATE REVENUE TO SUPPORT THE ONGOING MANAGEMENT AND ADMINISTRATION OF PROGRAMS. 1 HONORARIUM AND AWARDS 19 20745 INCENTIVE GRANTS 91 57772 SCHOLARSHIPS 26 31350 PART I, LINE 2: SCHOLARSHIPS AND/OR GRANTS ARE AWARDED BASED ON MERIT AND SPECIFIC CRITERIA. APPLICATIONS ARE APPROVED BY A SELECTION COMMITTEE OF EXPERTS SANCTIONED BY THE BOARD OF DIRECTORS. 1 0 0 0 0 0 0 1 0 SCOTT KNOER FORMER SECRETARY 0 0 0 0 0 683465 0 0 0 0 0 683465 0 0 ILISA BERNSTEIN SECRETARY (THRU 7/23) 0 432365 0 65881 0 25546 0 15328 0 5487 0 544607 0 65881 BENJAMIN BLUML EXEC DIR / SVP OF RESEARCH 267130 0 37804 0 1980 0 94038 0 12639 0 413591 0 37804 0 MICHAEL HOGUE SECRETARY (BEG 7/23) 0 302970 0 0 0 30736 0 19873 0 15101 0 368680 0 0 JONATHAN LITTLE RESEARCH & INNOVATION PROJ MGMT SPEC 141310 0 11038 0 223 0 31208 0 10925 0 194704 0 11038 0 BARRY BUNTING PROJECT MANAGEMENT SPECIALIST 116621 0 8456 0 4705 0 21461 0 23426 0 174669 0 8456 0 PART I, LINE 3 EMPLOYEES OF THE FOUNDATION ARE COMPENSATED BY A RELATED ORGANIZATION, AMERICAN PHARMACISTS ASSOCIATION (APHA). APHA USES INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEY OR STUDY, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE TO ESTABLISH THE COMPENSATION OF THE EXECUTIVE DIRECTOR. PART I, LINE 4A A SEVERANCE PAYMENT OF $683,465 WAS PAID TO SCOTT KNOER. PART I, LINE 7 THE FOUNDATION HAS A BONUS POLICY IN WHICH STAFF ARE PAID A BONUS IF THERE IS A NET SURPLUS AND STRATEGIC INITIATIVES AND INDIVIDUAL PERFORMANCE GOALS ARE ACHIEVED FORM 990, PART VI, SECTION A, LINE 6 THE MEMBERS OF THE FOUNDATION ARE THE BOARD OF DIRECTORS OF THE FOUNDATION AND THE MEMBERS OF THE BOARD OF TRUSTEES OF THE AMERICAN PHARMACISTS ASSOCIATION. FORM 990, PART VI, SECTION A, LINE 7A THE FOUNDATION'S BOARD SHALL BE APPOINTED BY THE MEMBERS OF THE BOARD OF TRUSTEES OF THE AMERICAN PHARMACISTS ASSOCIATION. FORM 990, PART VI, SECTION B, LINE 11B THE BOARD OF DIRECTORS REVIEWS THE FORM 990 BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C THE CONFLICT OF INTEREST POLICY IS REVIEWED AND SIGNED BY ALL THE BOARD OF DIRECTORS ANNUALLY. THE FOUNDATION EXECUTIVE DIRECTOR REVIEWS ANY BUSINESS TRANSACTIONS (COMPENSATION/SERVICES RENDERED) WITH BOARD MEMBERS AND THIS INFORMATION, IF ANY, IS DISCLOSED TO THE FOUNDATION'S LEGAL COUNSEL. LEGAL COUNSEL DISCLOSES THIS INFORMATION DURING THE EXECUTIVE SESSION OF THE BOARD OF DIRECTORS MEETINGS. FORM 990, PART VI, SECTION B, LINE 15A THE SECRETARY OF THE BOARD OF DIRECTORS APPROVES THE TOP MANAGEMENT OFFICIALS COMPENSATION. THE COMPENSATION IN THE EMPLOYMENT CONTRACT WAS DETERMINED THROUGH COMPARABILITY ANALYSIS CONDUCTED BY AN INDEPENDENT CONSULTANT. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS ARTICLES OF INCORPORATION, BYLAWS, CONFLICT OF INTEREST POLICY, AND AUDITED FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G MISCELLANEOUS: PROGRAM SERVICE EXPENSES 4,526,651. MANAGEMENT AND GENERAL EXPENSES 24,940. FUNDRAISING EXPENSES 5,568. TOTAL EXPENSES 4,557,159. FORM 990, PART XII, LINE 2C OVERSIGHT OF AUDIT HAS NOT CHANGED FROM PRIOR YEAR. AMERICAN PHARMACISTS ASSOCIATION 2215 CONSTITUTION AVENUE NW WASHINGTON DC 20037 530026265 MEMBERSHIP ORGANIZATION DC 501(C)(6) 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 0 1 1 AMERICAN PHARMACISTS ASSOCIATION K 137475 FMV AMERICAN PHARMACISTS ASSOCIATION P 1400363 FMV AMERICAN PHARMACISTS ASSOCIATION S 678080 FMV AMERICAN PHARMACISTS ASSOCIATION R 19154 FMV AMERICAN PHARMACISTS ASSOCIATION L 693142 FMV